Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Taghrid B El-Abaseri Author

Subjects of specialization
Retinoic acid, Verapamil, Troleandomycin

Affiliation
Department of Surgery University of Nebraska Medical Center, Omaha, NE, USA

Biography

Taghrid B El-Abaseri was working in the Department of Surgery University of Nebraska Medical Center, Omaha, NE, USA. she has more than 40 publications. Her research area focuses in Pancreatic cancer. He is specialised in Retinoic acid; Verapamil; Proliferation; Apoptosis; Pancreatic cancer


Publications

Research Article Open Access

Inhibition of Cytochrome P450 and Multidrug Resistance Proteins Potentiates the Efficacy of All-Trans Retinoic Acid in Pancreatic Cancer In Vitro and In Vivo

Author(s):

Taghrid B El-Abaseri, Tarek H El- Metwally, Patrick L Iversen and Thomas E Adrian

Objectives: All-trans retinoic acid (atRA) potently induces differentiation and apoptosis in pancreatic cancer. However, the clinical use of retinoids is limited by retinoid resistance or development of toxicity at high doses. We tested the hypothesis that blocking atRA degradation and elimination from the cell would potentiate its effectiveness in pancreatic cancer therapy.

Methods: In vitro, AsPc-1 and HPAF cells were co-treated with atRA and inhibitors of either multidrug resistance (MDR: verapamil, LY335979, and quinidine) or cytochrome P450 (CYP450s: troleandomycin, clotrimazole and liarozole). In addition, cells were co treated with atRA and antisense view moreĀ»

DOI: 10.4172/2324-9110.1000138

Abstract HTML PDF



Google Scholars / Researchers Sites

GET THE APP